Objectives
The aim of this study was to identify care settings associated with increased pressure ulcer risk among elderly hip fracture patients in the post-fracture period.
Design
Prospective cohort study.
Setting
Nine hospitals that participate in the Baltimore Hip Studies network and 105 postacute facilities to which patients from these hospitals were discharged.
Participants
Hip fracture patients age ≥65 years who underwent surgery for hip fracture.
Measurements
A full-body skin examination was conducted at baseline (as soon as possible after hospital admission) and repeated on alternating days for 21 days. Patients were deemed to have an acquired pressure ulcer (APU) if they developed ≥1 new pressure ulcers stage 2 or higher following hospital admission.
Results
Among 658 study participants, the APU cumulative incidence at 32 days after initial hospital admission was 36.1% (standard error 2.5%). Compared to home, the adjusted APU incidence rate was highest during the initial acute hospital stay (relative rate [RR] 2.2, 95% confidence interval [CI] 1.3–3.7) and during re-admission to the acute hospital (RR 2.2, 95% CI 1.1–4.2). The relative rates in rehabilitation and nursing home settings were 1.4 (95% CI 0.8–2.3) and 1.3 (95% CI 0.8–2.1), respectively.
Conclusion
Approximately one-third of hip fracture patients developed an APU during the study period. The rate was highest in the acute setting, a finding that is significant in light of Medicare’s policy of not reimbursing hospitals for the treatment of hospital-acquired pressure ulcers. Hip fracture patients constitute an important group to target for pressure ulcer prevention in hospitals.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.